Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial
Authors
Fang Wang (ORCID: https://orcid.org/0000-0001-7779-6957)
Zhuhua Cai (ORCID: https://orcid.org/0009-0005-3566-8697)
Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial
Fang Wang, Zhuhua Cai, Yaolong Chen, Xianghui Zeng et al.
Citations
1 citations
Journal
Trials
Topics
Reproductive System and Pregnancy
Field-Weighted Citation Impact (FWCI)
0.80
article
Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial
Fang Wang, Zhuhua Cai, Yaolong Chen, Xianghui Zeng, Qi Zhou, Lirong Du, Fangxiang Mu
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 26(1)
Institutions
Wenzhou Medical University (CN), Lanzhou University Second Hospital (CN), Lanzhou University (CN), Hebei Institute of Physical Education (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial — Fang Wang, Zhuhua Cai, et al. · Trials (2025) | TGRS Research Map | TGRS